Abnormal expression of VEGF and its gene transcription status as diagnostic indicators in patients with non-small cell lung cancer
暂无分享,去创建一个
[1] R. Cerfolio,et al. The efficacy of restaging endobronchial ultrasound in patients with non-small cell lung cancer after preoperative therapy. , 2014, The Annals of thoracic surgery.
[2] Caicun Zhou,et al. Prophylactic Cranial Irradiation May Impose a Detrimental Effect on Overall Survival of Patients with Nonsmall Cell Lung Cancer: A Systematic Review and Meta-Analysis , 2014, PloS one.
[3] H. Klomp,et al. FDG-PET/CT response evaluation during EGFR-TKI treatment in patients with NSCLC. , 2014, World journal of radiology.
[4] P. Ellis,et al. The Treatment of Metastatic Non-Small Cell Lung Cancer in the Elderly: An Evidence-Based Approach , 2014, Front. Oncol..
[5] M. Lackmann,et al. Vascular remodeling in cancer , 2014, Oncogene.
[6] K. O'Byrne,et al. Thromboxane synthase expression and correlation with VEGF and angiogenesis in non-small cell lung cancer. , 2014, Biochimica et biophysica acta.
[7] Cizhong Jiang,et al. Tumor resistance to anti-VEGF therapy through up-regulation of VEGF-C expression. , 2014, Cancer letters.
[8] S. Akira,et al. Roles of microsomal prostaglandin E synthase-1 in lung metastasis formation in prostate cancer RM9 cells. , 2014, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[9] J. Kurie,et al. Expression of TLR9 in tumor‐infiltrating mononuclear cells enhances angiogenesis and is associated with a worse survival in lung cancer , 2014, International journal of cancer.
[10] R. Rosell,et al. A Gene Signature Combining the Tissue Expression of Three Angiogenic Factors is a Prognostic Marker in Early-stage Non-small Cell Lung Cancer , 2014, Annals of Surgical Oncology.
[11] V. Awasthi,et al. Preclinical evaluation of 4‐[3,5‐bis(2‐chlorobenzylidene)‐4‐oxo‐piperidine‐1‐yl]‐4‐oxo‐2‐butenoic acid, in a mouse model of lung cancer xenograft , 2013, British journal of pharmacology.
[12] R. Jiang,et al. Experimental study of Endostar injection concomitant with cryoablation on lung adenocarcinoma A549 xenografts. , 2013, Asian Pacific journal of cancer prevention : APJCP.
[13] Tiehong Zhang,et al. A comparison on expression of selected biomarkers between primary lung cancers and matched metastases , 2013, Medical Oncology.
[14] W. Su,et al. Upregulation of Tissue Factor by Activated Stat3 Contributes to Malignant Pleural Effusion Generation via Enhancing Tumor Metastasis and Vascular Permeability in Lung Adenocarcinoma , 2013, PloS one.
[15] Kehu Yang,et al. The expression of hypoxia-inducible factor-1α and its clinical significance in lung cancer: a systematic review and meta-analysis. , 2013, Swiss medical weekly.
[16] Keyuan Zhou,et al. Epigallocatechin-3-Gallate Inhibits IGF-I-Stimulated Lung Cancer Angiogenesis through Downregulation of HIF-1α and VEGF Expression , 2013, Lifestyle Genomics.
[17] Yingying Wang,et al. Hypothermia Activates Adipose Tissue to Promote Malignant Lung Cancer Progression , 2013, PloS one.
[18] Ping Chen,et al. Clinical significance of survivin and VEGF mRNA detection in the cell fraction of the peripheral blood in non-small cell lung cancer patients before and after surgery. , 2013, Lung cancer.
[19] Yajuan Chen,et al. Anti-angiogenic activity of salvicine , 2013, Pharmaceutical biology.
[20] A. Pries,et al. Regulation of pro-angiogenic tissue factor expression in hypoxia-induced human lung cancer cells. , 2013, Oncology reports.
[21] Xue Meng,et al. Serum vascular endothelial growth factor-C levels: A possible diagnostic marker for lymph node metastasis in patients with primary non-small cell lung cancer , 2013, Oncology letters.
[22] Dong Wang,et al. Human Apurinic/Apyrimidinic Endonuclease siRNA Inhibits the Angiogenesis Induced by X-Ray Irradiation in Lung Cancer Cells , 2013, International journal of medical sciences.
[23] Hui Gao,et al. Digoxin Downregulates NDRG1 and VEGF through the Inhibition of HIF-1α under Hypoxic Conditions in Human Lung Adenocarcinoma A549 Cells , 2013, International journal of molecular sciences.
[24] Yunmei Yang,et al. Effects of autocrine vascular endothelial growth factor (VEGF) in non-small cell lung cancer cell line A549 , 2013, Molecular Biology Reports.
[25] F. Arias,et al. Prognostic significance of the expression of vascular endothelial growth factors A, B, C, and D and their receptors R1, R2, and R3 in patients with nonsmall cell lung cancer , 2009, Cancer.
[26] Ling-hua Meng,et al. Systematic combination screening reveals synergism between rapamycin and sunitinib against human lung cancer. , 2014, Cancer letters.
[27] Ping Chen,et al. Over-expression of survivin and VEGF in small-cell lung cancer may predict the poorer prognosis , 2013, Medical Oncology.
[28] Chih-Teng Yu,et al. Elevated circulating levels of tissue factor-positive microvesicles are associated with distant metastasis in lung cancer , 2013, Journal of Cancer Research and Clinical Oncology.